e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Lung cancer: molecular pathology and functional genomics
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Non-coding RNA as functional player and molecular marker in lung cancer
M. Polycarpou-Schwarz, T. Gutschner, S. Grund, A. Warth, H. Zabeck, C. Hildenbrand, M. Baas, M. Meister, T. Muley, P. Schirmacher, H. Hoffmann, P. Schnabel, S. Diederichs (Heidelberg, Germany)
Source:
Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Session:
Lung cancer: molecular pathology and functional genomics
Session type:
Poster Discussion
Number:
1959
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Polycarpou-Schwarz, T. Gutschner, S. Grund, A. Warth, H. Zabeck, C. Hildenbrand, M. Baas, M. Meister, T. Muley, P. Schirmacher, H. Hoffmann, P. Schnabel, S. Diederichs (Heidelberg, Germany). Non-coding RNA as functional player and molecular marker in lung cancer. Eur Respir J 2011; 38: Suppl. 55, 1959
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Wiewrodt Rainer - 27.11.2011 10:49
Very nice!
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
DNA methylation markers of surfactant proteins in lung cancer
Source: Annual Congress 2007 - Novel mediators of cellular pathology
Year: 2007
MicroRNAs in human lung cancer and human lung embryogenesis
Source: Eur Respir J 2007; 30: Suppl. 51, 428s
Year: 2007
Causal RNA signatures in lung adenocarcinoma
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Polymorphisms in telomere maintenance genes and risk of lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?
Source: Eur Respir J 2015; 46: 1548-1550
Year: 2015
Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Where next for lung cancer gene expression profiling?
Source: Eur Respir J 2007; 30: 5-6
Year: 2007
Differential expression analysis of lncRNA in different types of lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Mutational RNA signatures in environmentally-induced lung adenocarcinoma
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
An analysis of mRNA and long non-coding RNA (lncRNA) expression during the progression from pre-invasive lesions (PL) to invasive squamous cell carcinoma (SqCC) of the bronchus
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
PP135 – Mutational RNA signatures in environmentally-induced lung adenocarcinoma
Source: ERS Lung Science Conference 2021
Year: 2021
Lung cancer biomarkers based on miRNA
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Telomerase activity as a prognostic marker in non small cell lung cancer
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
Identification of reference genes in lung cancer from RNA-seq data
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Gene regulation of apoptosis and telomere length in COPD and lung cancer
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Association between polymorphisms in microRNA target sites using CLASH data and survival of early-stage non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Fusion transcripts in lung cancer
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept